Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China flag China · Delayed Price · Currency is CNY
30.55
-1.70 (-5.27%)
May 21, 2026, 3:04 PM CST

SHE:301130 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
234.84255.25225.14255.4285.14
Other Revenue
-1.160.350.070.51
234.84256.41225.49255.47285.66
Revenue Growth (YoY)
-8.41%13.71%-11.73%-10.57%-0.23%
Cost of Revenue
55.7461.1645.5247.4246.98
Gross Profit
179.1195.24179.97208.05238.68
Selling, General & Admin
148.24144.9142.24153.66168.88
Research & Development
11.2510.228.711.7413.31
Other Operating Expenses
2.474.975.886.427.92
Operating Expenses
161.96160.74156.29171.77190.43
Operating Income
17.1434.523.6936.2848.25
Interest Expense
--0.07-0.05--
Interest & Investment Income
36.8213.3511.363.85
Other Non Operating Income (Expenses)
0.92-0.06-0.05-0.01-0.04
EBT Excluding Unusual Items
21.0541.236.9347.6352.05
Gain (Loss) on Sale of Investments
0.940.743.151.17-
Gain (Loss) on Sale of Assets
--0.51.87--
Asset Writedown
-0.99-0-0.17-0-0.17
Other Unusual Items
-5.0816.531.647.32
Pretax Income
2146.5158.3150.4359.21
Income Tax Expense
1.16.257.819.717.19
Earnings From Continuing Operations
19.940.2750.540.7252.02
Minority Interest in Earnings
2----
Net Income
21.940.2750.540.7252.02
Net Income to Common
21.940.2750.540.7252.02
Net Income Growth
-45.62%-20.26%24.01%-21.71%4.58%
Shares Outstanding (Basic)
7678817761
Shares Outstanding (Diluted)
7678817761
Shares Change (YoY)
-1.74%-3.66%4.35%27.78%-0.00%
EPS (Basic)
0.290.520.630.530.86
EPS (Diluted)
0.290.520.630.530.86
EPS Growth
-44.66%-17.23%18.84%-38.73%4.58%
Free Cash Flow
-17.44-80.73-68.7912.8337.83
Free Cash Flow Per Share
-0.23-1.04-0.850.170.62
Dividend Per Share
-0.2600.2600.1600.130
Dividend Growth
--62.50%23.08%-
Gross Margin
76.26%76.15%79.81%81.44%83.55%
Operating Margin
7.30%13.46%10.50%14.20%16.89%
Profit Margin
9.32%15.71%22.40%15.94%18.21%
Free Cash Flow Margin
-7.43%-31.49%-30.51%5.02%13.24%
EBITDA
52.456.9242.2354.7766.96
EBITDA Margin
22.31%22.20%18.73%21.44%23.44%
D&A For EBITDA
35.2622.4218.5518.4918.71
EBIT
17.1434.523.6936.2848.25
EBIT Margin
7.30%13.46%10.50%14.20%16.89%
Effective Tax Rate
5.23%13.43%13.39%19.25%12.14%
Revenue as Reported
-256.41225.49255.47285.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.